This further substantiates that HSF1 is a critical target through which WMW exerts its therapeutic effects on obesity, indicating the importance of the HSF1 pathway in the browning process and overall metabolic regulation. The gene discussed is HSF1; the disease is obesity due to melanocortin 4 receptor deficiency.